e

eFFECTOR Therapeutics, Inc.

27 employees

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Medical

Date founded

2012

Funding rounds raised

Total raised

$60M

from 23 investors over 23 rounds

e

eFFECTOR Therapeutics, Inc. raised $60M on August 26, 2021

Investors: Abingworth, The Column Group, S.R. One Ltd, Osage University Partners (OUP) and Sectoral Asset Management

e

eFFECTOR Therapeutics, Inc. raised $39M on July 24, 2017

Investors: Mission BioCapital, Osage University Partners (OUP), Sectoral Asset Management, S.R. One Ltd, Astellas Venture Capital L.L.C. and The Column Group

e

eFFECTOR Therapeutics, Inc. raised $16M on February 19, 2016

Investors: Sectoral Asset Management

e

eFFECTOR Therapeutics, Inc. raised $40M on December 23, 2015

Investors: Osage University Partners (OUP), Abingworth, Astellas Venture Capital L.L.C., Mission Bay Capital, The Column Group and S.R. One Ltd

e

eFFECTOR Therapeutics, Inc. raised $45M on May 20, 2013

Investors: S.R. One Ltd, Abingworth, Osage University Partners (OUP), Mission Bay Capital and Astellas Venture Capital L.L.C.